Reuters logo
3 months ago
BRIEF-Sage Therapeutics initiates phase 1 single ascending dose trial
April 27, 2017 / 12:02 PM / 3 months ago

BRIEF-Sage Therapeutics initiates phase 1 single ascending dose trial

1 Min Read

April 27 (Reuters) - Sage Therapeutics Inc:

* Sage Therapeutics - initiated phase 1 single ascending dose (SAD) trial of sage-718; top-line results from sad study are expected in 2H of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below